Home > Riviste > Journal of Neurosurgical Sciences > Fascicoli precedenti > Journal of Neurosurgical Sciences 2010 March;54(1) > Journal of Neurosurgical Sciences 2010 March;54(1):29-37

ULTIMO FASCICOLO
 

ARTICLE TOOLS

Estratti

JOURNAL OF NEUROSURGICAL SCIENCES

Rivista di Neurochirurgia


Indexed/Abstracted in: e-psyche, EMBASE, PubMed/MEDLINE, Neuroscience Citation Index, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 1,651


eTOC

 

ORIGINAL ARTICLES  


Journal of Neurosurgical Sciences 2010 March;54(1):29-37

Copyright © 2010 EDIZIONI MINERVA MEDICA

lingua: Inglese

The effect of the sildenafil citrate on cerebral vasospasm and apoptosis following experimental subarachnoid hemorrhage in rats

Gokce C., Gulsen S., Yilmaz C., Guven G., Caner H., Altinors N.

1 Department of Neurosurgery, Baskent University, Ankara, Turkey;
2 Department of Pathology, Baskent University, Ankara, Turkey


PDF  


AIM: The therapeutic effect of sildenafil citrate on cerebral vasospasm after experimental subarachnoid hemorrhage (SAH) was studied in a rat model.
METHODS: We used four groups of seven rats were as follows: no SAH, no treatment; SAH only; SAH plus 2 days of peroral sildenafil citrate 5mg/kg treatment and SAH plus 2 days of peroral sildenafil citrate 15 mg/kg treatment. Three different parameters were evaluated including the diameter of the basilar artery, the level of lipid peroxidation and the degree of the apoptosis 48 hours following SAH.
RESULTS: The results showed that sildenafil citrate attenuated SAH-induced cerebral vasospasm in the treatment groups in terms of the diameter of the basilar artery and lipid peroxidation in the two treatment groups, but there was no difference in terms of the level of apoptosis.
CONCLUSION: This study indicates that further research on the therapeutic effect of sildenafil citrate can be combined with the use of any apoptosis-blocking agent for the treatment of cerebral vasospasm following experimental subarachnoid hemorrhage.

inizio pagina

Publication History

Per citare questo articolo

Corresponding author e-mail

salihgulsen07@gmail.com